Luting Zhou
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
-
- Renal and related cancers
- RNA modifications and cancer
- Circular RNAs in diseases
- Ubiquitin and proteasome pathways
Papers in ⓘ
-
- Renal and related cancers 15
-
- Renal cell carcinoma treatment 16
- Medical Imaging and Pathology Studies 5
- Sarcoma Diagnosis and Treatment 4
- Co-authors
- Chaofu Wang (29 shared papers)Ming Geng (3 shared papers)Jun Zhou (15 shared papers)Ling Li (2 shared papers)Xiaoqun Yang (23 shared papers)Kejia Wang (1 shared paper)Hui Li (1 shared paper)Haimin Xu (19 shared papers)
- Journals
- Pathology International (4 papers)Human Pathology (2 papers)Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (2 papers)BioMed Research International (2 papers)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Luting Zhou
43 papers receiving 585 citations
Peers
Comparison fields: 5 of 92
- Cancer Research 152
- Molecular Biology 304
- Pulmonary and Respiratory Medicine 133
- Biological Psychiatry 9
- Hepatology 26
Countries citing papers authored by Luting Zhou
This map shows the geographic impact of Luting Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luting Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luting Zhou more than expected).
Fields of papers citing papers by Luting Zhou
This network shows the impact of papers produced by Luting Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luting Zhou. The network helps show where Luting Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Luting Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 79 | |
| 2 | MicroRNA-543 acts as an oncogene by targeting PAQR3 in hepatocellular carcinoma. | 2014 | 60 |
| 3 | 2017 | 54 | |
| 4 | 2012 | 42 | |
| 5 | Expression of Wnt-5a and β-catenin in primary hepatocellular carcinoma. | 2014 | 36 |
| 6 | 2020 | 32 | |
| 7 | 2015 | 27 | |
| 8 | 2022 | 27 | |
| 9 | 2019 | 20 | |
| 10 | 2012 | 19 | |
| 11 | 2020 | 17 | |
| 12 | 2020 | 17 | |
| 13 | 2022 | 15 | |
| 14 | 2021 | 14 | |
| 15 | 2021 | 13 | |
| 16 | 2019 | 12 | |
| 17 | Hyperbaric oxygen treatment reduced the lung injury of type II decompression sickness. | 2015 | 11 |
| 18 | 2022 | 9 | |
| 19 | 2019 | 9 | |
| 20 | 2019 | 9 |
About Luting Zhou
Luting Zhou is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Surgery, Cancer Research and Rheumatology, having authored 49 papers that have together received 589 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (16 papers), Renal and related cancers (15 papers), Medical Imaging and Pathology Studies (5 papers), Cancer Genomics and Diagnostics (5 papers), Soft tissue tumor case studies (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Sarcoma Diagnosis and Treatment (4 papers) and Lipid metabolism and biosynthesis (3 papers). The work is most often cited by research in Cancer Research (152 citations), Molecular Biology (304 citations), Pulmonary and Respiratory Medicine (133 citations), Biological Psychiatry (9 citations) and Hepatology (26 citations). Luting Zhou has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Chaofu Wang, Ming Geng, Jun Zhou, Ling Li, Xiaoqun Yang, Kejia Wang, Hui Li, Haimin Xu, Weiping J. Zhang and Zhifang Xie. Their work appears in journals such as Pathology International, Human Pathology, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, BioMed Research International and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.